Name: Rhythm Biosciences (RHY) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

RHY

Rhythm Biosciences

Health Care Equipment & Services

Rhythm Biosciences is an Australian medical diagnostics company focused on developing and commercializing innovative diagnostic technologies for early cancer detection. Their primary focus is ColoSTAT, a non-invasive blood test for the early detection of colorectal cancer, offering a more accessible alternative to traditional screening methods. Rhythm aims to transform cancer diagnostics by providing precise and accessible screening solutions, empowering patients and healthcare systems with critical insights.

Short position

short percentage0.00%

reported shorts8.1K

shares on issue353.867M

Rhythm Biosciences (ASX:RHY) has 0.00% of its shares on issue reported as short positions as of 25 May 2026, or about 8,122 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.69% in July 2023. RHY is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.